CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 133 filers reported holding CYTOKINETICS INC in Q2 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,190,727 | +442.4% | 1,533,969 | +500.6% | 0.09% | +475.0% |
| Q2 2023 | $8,330,887 | -68.2% | 255,392 | -65.7% | 0.02% | -71.4% |
| Q1 2023 | $26,227,353 | -43.4% | 745,307 | -26.3% | 0.06% | -46.2% |
| Q4 2022 | $46,345,189 | +0.1% | 1,011,462 | +5.8% | 0.10% | +3.0% |
| Q3 2022 | $46,313,000 | -12.9% | 955,886 | -29.4% | 0.10% | -7.3% |
| Q2 2022 | $53,164,000 | +4571.7% | 1,353,137 | +4278.4% | 0.11% | +5350.0% |
| Q1 2022 | $1,138,000 | -43.5% | 30,905 | -30.0% | 0.00% | -50.0% |
| Q4 2021 | $2,014,000 | -23.2% | 44,171 | -66.7% | 0.00% | -66.7% |
| Q2 2021 | $2,622,000 | -58.8% | 132,497 | -51.6% | 0.01% | -58.6% |
| Q1 2021 | $6,371,000 | +486.6% | 273,906 | +423.9% | 0.03% | +383.3% |
| Q4 2020 | $1,086,000 | -75.8% | 52,278 | -74.8% | 0.01% | -79.3% |
| Q3 2020 | $4,491,000 | +3354.6% | 207,453 | +1197.2% | 0.03% | +2800.0% |
| Q1 2019 | $130,000 | +154.9% | 15,992 | +100.0% | 0.00% | 0.0% |
| Q4 2018 | $51,000 | -76.8% | 7,996 | -73.9% | 0.00% | -88.9% |
| Q1 2018 | $220,000 | – | 30,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 325,000 | $6,754,000 | 6.26% |
| RP Management, LLC | 875,656 | $18,196,000 | 5.58% |
| BVF INC/IL | 4,878,035 | $101,366,000 | 3.99% |
| Burrage Capital Management LLC | 246,036 | $5,113,000 | 3.90% |
| Integral Health Asset Management, LLC | 525,000 | $10,910,000 | 3.24% |
| Foresite Capital Management IV, LLC | 1,435,992 | $29,840,000 | 3.24% |
| Opaleye Management Inc. | 582,800 | $12,111,000 | 1.58% |
| Boxer Capital, LLC | 2,100,000 | $43,638,000 | 1.40% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 3,226,567 | $67,048,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,461,000 | $51,140,000 | 1.01% |